← All trials
NCT04864444
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 19, 2021
- Primary completion
- Dec 31, 2022
- Completion date
- Dec 31, 2022
- First posted
- Apr 28, 2021
- Last posted
- Jul 12, 2021
- Enrollment
- 24000
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of California, San FranciscoLead sponsor
- University of California, San FranciscoOverall official - principal investigator
- Centers for Disease Control and Prevention (CDC)Collaborator
- US President's Malaria InitiativeCollaborator
- US President's Malaria InitiativeOverall official - principal investigator
- Université de ThièsOverall official - principal investigator
- Université de ThièsCollaborator
- Government of SenegalOverall official - principal investigator
- Government of SenegalCollaborator
- Population Services InternationalCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.